{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:38:34Z","timestamp":1761748714514,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T00:00:00Z","timestamp":1543708800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.acvd.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T05:30:48Z","timestamp":1509946248000},"page":"682-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent"],"prefix":"10.1016","volume":"110","author":[{"given":"Luc","family":"Maillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Tavildari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Peycher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vochelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2017.04.010_bib0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0215","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0735-1097(01)01207-4","article-title":"Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial","volume":"37","author":"Kiemeneij","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0220","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0735-1097(00)00612-4","article-title":"A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction","volume":"35","author":"Maillard","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0225","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","article-title":"Coronary angioplasty with or without stent implantation for acute myocardial infarction","volume":"341","author":"Grines","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0230","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0235","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","article-title":"Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial","volume":"50","author":"Morice","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0240","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.04.010_bib0245","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(12)61336-1","article-title":"Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial","volume":"380","author":"Camenzind","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2017.04.010_bib0250","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"Navarese","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2017.04.010_bib0255","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2009.02.007","article-title":"Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice","volume":"157","author":"Goy","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2017.04.010_bib0260","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jacc.2004.09.079","article-title":"Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4244\/EIJV9I3A52","article-title":"Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent","volume":"9","author":"Meredith","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2017.04.010_bib0270","first-page":"1160","article-title":"Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC single centre real world PCI registry","volume":"10","author":"Kraak","year":"2015","journal-title":"Euro Interv"},{"key":"10.1016\/j.acvd.2017.04.010_bib0275","first-page":"1144","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"Eur Interv"},{"key":"10.1016\/j.acvd.2017.04.010_bib0280","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.04.010_bib0285","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacc.2010.11.028","article-title":"tent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (multi-center post-market surveillance) registry","volume":"57","author":"Urban","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0290","first-page":"794078","article-title":"Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: a meta-analysis","author":"Kwok","year":"2014","journal-title":"Scientific World J"},{"key":"10.1016\/j.acvd.2017.04.010_bib0295","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0300","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.mca.0000084940.36114.94","article-title":"Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model","volume":"14","author":"Huang","year":"2003","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.acvd.2017.04.010_bib0310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.rli.0000156195.74967.47","article-title":"A new polymer concept for coating of vascular stents using PTFEP (poly-bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis","volume":"40","author":"Richter","year":"2005","journal-title":"Invest Radiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.rli.0000261439.90760.9d","article-title":"The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model","volume":"42","author":"Satzl","year":"2007","journal-title":"Invest Radiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0320","first-page":"89","article-title":"Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents","volume":"32","author":"Mrowietz","year":"2005","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.acvd.2017.04.010_bib0325","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jcis.1997.5238","article-title":"Plasma protein adsorption and platelet adhesion on Poly","volume":"197","author":"Welle","year":"1998","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.acvd.2017.04.010_bib0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jvir.2007.12.450","article-title":"Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents","volume":"19","author":"Henn","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0335","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00270-008-9392-7","article-title":"Reduction of late in-stent stenosis in a porcine coronary artery model by cobalt chromium stents with a nanocoat of polyphosphazene (Polyzene-F)","volume":"31","author":"Stampfl","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0340","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00270-007-9243-y","article-title":"Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model","volume":"31","author":"Radeleff","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heart.89.2.133","article-title":"Drug eluting stents: are human and animal studies comparable?","volume":"89","author":"Virmani","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2017.04.010_bib0350","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.04.010_bib0355","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.04.010_bib0360","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00392-009-0061-x","article-title":"Cobalt-chrome MULTI-LINK VISION-stent implantation in diabetics and complex lesions: results from the DaVinci-Registry","volume":"98","author":"Nef","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.carrev.2014.12.007","article-title":"Primary endpoint results of the OMEGA study: one-year clinical outcomes after implantation of a novel platinum chromium bare metal stent","volume":"16","author":"Wang","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0370","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.04.010_bib0375","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2017.04.010_bib0380","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines and the society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0385","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ahj.2004.06.003","article-title":"Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"149","author":"Avezum","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2017.04.010_bib0390","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0395","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0400","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2017.04.010_bib0405","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8183.2009.00516.x","article-title":"Radial artery access as an emerging factor for decreasing mortality in cardiovascular interventions","volume":"23","author":"Cevik","year":"2010","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.acvd.2017.04.010_bib0410","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.amjcard.2011.11.007","article-title":"Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention","volume":"109","author":"Joyal","year":"2012","journal-title":"Am J Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213617301833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213617301833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:44:16Z","timestamp":1761745456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213617301833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1875213617301833"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2017.04.010","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}